{"id":"https://openalex.org/W4366523908","doi":"https://doi.org/10.1158/1078-0432.22665307","title":"Supplementary Figure S4 from Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis","display_name":"Supplementary Figure S4 from Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis","publication_year":2023,"publication_date":"2023-04-20","ids":{"openalex":"https://openalex.org/W4366523908","doi":"https://doi.org/10.1158/1078-0432.22665307"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22665307","doi":"https://doi.org/10.1158/1078-0432.22665307","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22665307","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22665307","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055282224","display_name":"Chong Kin Liam","orcid":"https://orcid.org/0000-0002-3639-9231","observed_orcids":["https://orcid.org/0000-0002-3639-9231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chong Kin Liam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3639-9231","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030416477","display_name":"Azura Rozila Ahmad","orcid":"https://orcid.org/0000-0003-3301-8656","observed_orcids":["https://orcid.org/0000-0003-3301-8656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Azura Rozila Ahmad","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3301-8656","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074784103","display_name":"Te\u2010Chun Hsia","orcid":"https://orcid.org/0000-0003-4297-9918","observed_orcids":["https://orcid.org/0000-0003-4297-9918","https://orcid.org/0000-0002-7294-7055"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Te-Chun Hsia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4297-9918","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052132950","display_name":"Jianying Zhou","orcid":"https://orcid.org/0000-0002-8924-935X","observed_orcids":["https://orcid.org/0000-0002-8924-935X","https://orcid.org/0009-0003-7889-3451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianying Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8924-935X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100638261","display_name":"Dong\u2010Wan Kim","orcid":"https://orcid.org/0000-0001-5124-7132","observed_orcids":["https://orcid.org/0000-0001-5124-7132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong-Wan Kim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5124-7132","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032293215","display_name":"Ross Andrew Soo","orcid":"https://orcid.org/0000-0002-3053-3997","observed_orcids":["https://orcid.org/0000-0002-3053-3997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ross Andrew Soo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3053-3997","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057704753","display_name":"Ying Cheng","orcid":"https://orcid.org/0000-0001-9908-597X","observed_orcids":["https://orcid.org/0000-0001-9908-597X","https://orcid.org/0009-0006-2718-2969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Cheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9908-597X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004928583","display_name":"Shun L\u00fc","orcid":"https://orcid.org/0000-0001-8833-7262","observed_orcids":["https://orcid.org/0000-0001-8833-7262"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shun Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8833-7262","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057550966","display_name":"Sang Won Shin","orcid":"https://orcid.org/0000-0002-9182-1589","observed_orcids":["https://orcid.org/0000-0002-9182-1589"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sang Won Shin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9182-1589","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055074037","display_name":"James Chih\u2010Hsin Yang","orcid":"https://orcid.org/0000-0002-5586-5138","observed_orcids":["https://orcid.org/0000-0002-5586-5138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Chih-Hsin Yang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5586-5138","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080162254","display_name":"Yiping Zhang","orcid":"https://orcid.org/0009-0000-2833-8626","observed_orcids":["https://orcid.org/0009-0000-2833-8626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiping Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-2833-8626","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100681890","display_name":"Jun Zhao","orcid":"https://orcid.org/0000-0003-1464-7158","observed_orcids":["https://orcid.org/0000-0003-1464-7158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1464-7158","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030186225","display_name":"Karin Berghoff","orcid":"https://orcid.org/0000-0002-6310-3379","observed_orcids":["https://orcid.org/0000-0002-6310-3379"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Berghoff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6310-3379","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055627152","display_name":"Rolf Bruns","orcid":"https://orcid.org/0000-0003-2305-3765","observed_orcids":["https://orcid.org/0000-0003-2305-3765"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rolf Bruns","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2305-3765","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005665121","display_name":"Andreas Johne","orcid":"https://orcid.org/0000-0003-2690-2857","observed_orcids":["https://orcid.org/0000-0003-2690-2857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Johne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2690-2857","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100632072","display_name":"Yi-Long Lung Cancer Wu","orcid":"https://orcid.org/0000-0002-3611-0258","observed_orcids":["https://orcid.org/0000-0002-3611-0258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi-Long Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3611-0258","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tepotinib","display_name":"tepotinib","score":0.859000027179718},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.9929999709129333},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.9160000085830688},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.9300000071525574},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6240000128746033},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8086369037628174},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5087528824806213},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5025036334991455},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5004160404205322},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.493615984916687},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.48523688316345215},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4247603118419647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21715816855430603},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.18782958388328552},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18639177083969116},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12688148021697998},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10312700271606445}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22665307","doi":"https://doi.org/10.1158/1078-0432.22665307","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22665307","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22665307","doi":"https://doi.org/10.1158/1078-0432.22665307","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22665307","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361000448","https://openalex.org/W4402817599","https://openalex.org/W4282967501","https://openalex.org/W4294939450","https://openalex.org/W4310754862"],"abstract_inverted_index":{"Treatment-related":[0],"adverse":[1],"events":[2],"in":[3],"treated":[4],"patients":[5],"with":[6],"MET":[7,10],"amplification":[8],"and/or":[9],"IHC":[11],"2+/3+":[12]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2023-04-22T00:00:00"}